FOXM1 and cancer: For instance, the small molecule compound C6 has demonstrated strong binding to both the WIN site and WDR5 Tyr191-related B site (50), resulting in enhanced anti-cancer efficacy by promoting p53-dependent apoptosis in leukemia cells.